Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing JNJ-77242113 for plaque psoriasis involving special areas (scalp, genital, palms, and/or soles), currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JNJ-77242113

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING